Murine norovirus: An intercurrent variable in a mouse model of bacteria-induced inflammatory bowel disease

Comparative Medicine

Volumn 58, Issue 6, 2008, Pages 522-533

  Lencioni, Karen Chase ^a   Seamons, Audrey ^b   Treuting, Piper M ^b   Maggio Price, Lillian ^b   Brabb, Thea ^b  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; CD4 CD8 RATIO; CELL ISOLATION; CELL POPULATION; COLITIS; CONTROLLED STUDY; COW; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE COURSE; ENTERITIS; FLOW CYTOMETRY; HELICOBACTER BILIS; HELICOBACTER INFECTION; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IN VITRO STUDY; INOCULATION; MIXED INFECTION; MOUSE; NONHUMAN; NOROVIRUS; T LYMPHOCYTE; VIRUS INFECTION; WEIGHT REDUCTION;

ANIMALS; CALICIVIRIDAE INFECTIONS; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; FEMALE; HELICOBACTER; HELICOBACTER INFECTIONS; IMMUNE TOLERANCE; IMMUNITY, INNATE; INFLAMMATORY BOWEL DISEASES; INTERFERON-GAMMA; MALE; MICE; MICE, KNOCKOUT; NOROVIRUS; P-GLYCOPROTEINS;

EID: 59049094068     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. American Veterinary Medical Association Panel on Euthanasia. 2001. 2000 Report of the AVMA Panel on Euthanasia. J Am Vet Med Assn 218:669-696
2. Asselin-Paturel C, Boonstra A, Dalod M, Durand I, Yessaad N, Dezutter-Dambuyant C, Vicari A, O'Garra A, Biron C, Briere F, Trinchieri G. 2001. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat Immunol 2:1144-1150.
3. Brabb T, von Dassow P, Ordonez N, Schnabel B, Duke B, Gover-man J. 2000. In situ tolerance within the central nervous system as a mechanism for preventing autoimmunity. J Exp Med 192:871-880.
4. Burich A, Hershberg R, Waggie K, Zeng W, Brabb T, Wesrrich G, Viney JL, Maggio-Price L. 2001. Helicobacter-induced inflammatory bowel disease in IL-10- and T cell-deficient mice. Am J Physiol Gastrointest Liver Physiol 281:G764-G778.
5. Cahill RJ, Foltz CJ, Fox JG, Dangler CA, Powrie F, Schauer DB. 1997. Inflammatory bowel disease: an immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus. Infect Immun 65:3126-3131.
6. Chachu KA, Strong DW, LoBue AD, Wobus CE, Baric RS, Virgin HW 4th. 2008. Antibody is critical for the clearance of MNV infection. I Virol 82:6610-6617.
7. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
8. Cousens LP, Orange JS, Su HC, Biron CA. 1997. Interferon-alpha/ beta inhibition of interleukin 12 and interferon-gamma production in vitro and endogenously during viral infection. Proc Natl Acad Sci USA 94:634-639.
9. Elson CO, Cong Y, McCracken VJ, Dimmitt RA, Lorenz RG, Weaver CT. 2005. Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol Rev 206:260-276.
10. Fallon MT, Benjamin WH Jr, Schoeb TR, Briles DE. 1991. Mouse hepatitis virus strain UAB infection enhances resistance to Salmonella typhimurium in mice by inducing suppression of bacterial growth. Infect Immun 59:852-856.
11. Fleeton M, Contractor N, Leon F, He J, Wetzel D, Dermody T, Iwasaki A, Kelsall B. 2004. Involvement of dendritic cell subsets in the induction of oral tolerance and immunity. Ann N Y Acad Sci 1029:60-65.
12. Hommes DW, Sterringa G, van Deventer SJ, Tytgat GN, Weel J. 2004. The pathogenicity of cytomegalovirus in inflammatory bowel disease: a systematic review and evidence-based recommendations for future research. Inflamm Bowel Dis 10:245-250.
13. Horwitz BH. 2007. The straw that stirs the drink: insight into the pathogenesis of inflammatory bowel disease revealed through the study of microflora-induced inflammation in genetically modified mice. Inflamm Bowel Dis 13:490-500.
14. Hsu CC, Riley LK, Livingston RS. 2007. Molecular characterization of three novel murine noroviruses. Virus Genes 34:147-155.
15. Hsu CC, Riley LK, Wills HM, Livingston RS. 2006. Persistent infection with and serologic cross-reactivity of three novel murine noroviruses. Comp Med 56:247-251.
16. Hsu CC, Wobus CE, Steffen EK, Riley LK, Livingston RS. 2005. Development of a microsphere-based serologic multiplexed fluorescent immunoassay and a reverse transcriptase PCR assay to detect murine norovirus 1 infection in mice. Clin Diagn Lab Immunol 12:1145-1151.
17. Kadowaki N, Antonenko S, Lau JY, Liu YJ. 2000. Natural interferon alpha/beta-producing cells link innate and adaptive immunity. J Exp Med 192:219-226.
18. Kandiel A, Lashner B. 2006. Cytomegalovirus colitis complicatinginflammatory bowel disease. Am J Gastroenterol 101:2857-2865.
19. Karst SM, Wobus CE, Lay M, Davidson J, Virgin HW 4th. 2003. STATl-dependent innate immunity to a Norwalk-like virus. Science 299:1575-1578.
20. Loftus EV Jr. 2004. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 126:1504-1517.
21. Maggio-Price L, Bielefeldt-Ohmann H, Treuting P, Iritani BM, Zeng W, Nicks A, Tsang M, Shows D, Morrissey P, Viney JL. 2005.Dual infection with Helicobacter bilis and Helicobacter hepaticus in p-glycoprotein-deficient mdrla-/- mice results in colitis that progresses to dysplasia. Am J Pathol 166:1793-1806.
22. Maggio-Price L, Shows D, Waggie K, Burich A, Zeng W, Escobar S, Morrissey P, Viney JL. 2002. Helicobacter bilis infection accelerates and H. hepaticus infection delays the development of colitis in multiple drug resistance-deficient (mdrla-/-) mice. Am J Pathol 160:739-751.
23. Maggio-Price L, Treuting P, Zeng W, Tsang M, Bielefeldt-Ohmann H, Iritani BM. 2006. Helicobacter infection is required for inflammation and colon cancer in SMAD3-deficient mice. Cancer Res 66:828-838.
24. Manuel CA, Hsu CC, Riley LK, Livingston RS. 2006. Research Animal Diagnostic Laboratory (RADIL). 57th AALAS National Meeting; 2006 Oct 15-19; Salt Lake City, UT.
25. Muller B, Klemm U, Mas Marques A, Schreier E. 2007. Genetic diversity and recombination of murine noroviruses in immunocompromised mice. Arch Virol 152:1709-1719.
26. Mumphrey SM, Changotra H, Moore TN, Heimann-Nichols ER, Wobus CE, Reilly MJ, Moghadamfalahi M, Shukla D, Karst SM. 2007. Murine norovirus 1 infection is associated with histopathological changes in immunocompetent hosts, but clinical disease is prevented by STATl-dependent interferon responses. J Virol 81:3251-3263.
27. Perdue KA, Green KY, Copeland M, Barron E, Mandel M, Fauc-ette LJ, Williams EM, Sosnovtsev SV, Elkins WR, Ward JM. 2007. Naturally occurring murine norovirus infection in a large research institution. J Am Assoc Lab Anim Sci 46:39-45.
28. Fodolsky DK. 2002. Inflammatory bowel disease. N Engl J Med 347:417-429.
29. Sugieda M, Nagaoka H, Kakishima Y, Ohshita T, Nakamura S, Nakajima S. 1998. Detection of Norwalk-like virus genes in the caecum contents of pigs. Arch Virol 143:1215-1221.
30. Thackray LB, Wobus CE, Chachu KA, Liu B, Alegre ER, Henderson KS, Kelley ST, Virgin HW 4th. 2007. Murine noroviruses comprising a single genogroup exhibit biological diversity despite limited sequence divergence. J Virol 81:10460-10473.
31. Torrence A, Brabb T, Viney J, Bielefeldt-Ohmann H, Treuting P, Seamons A, Zeng W, Maggio-Price L. 2008. Serum biomarkers in a mouse model of bacterial-induced inflammatory bowel disease. Inflamm Bowel Dis. 14:480-490.
32. Trinchieri G. 2003. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3:133-146.
33. Uguccioni M, Gionchetti P, Robbiani DF, Rizzello F, Peruzzo S, Campieri M, Baggiolini M. 1999. Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis. Am J Pathol 155:331-336.
34. van Der Poel WH, Vinje J, van Der Heide R, Herrera MI, Vivo A, Koopmans MP. 2000. Norwalk-like calicivirus genes in farm animals. Emerg Infect Dis 6:36-41.
35. Ward JM, Wobus CE, Thackray LB, Erexson CR, Faucette LJ, Bel-liot G, Barron EL, Sosnovtsev SV, Green KY. 2006. Pathology of immunodeficient mice with naturally occurring murine norovirus infection. Toxicol Pathol 34:708-715.
36. Wobus CE, Karst SM, Thackray LB, Chang KO, Sosnovtsev SV, Belliot G, Krug A, Mackenzie JM, Green KY, Virgin HW. 2004. Replication of norovirus in cell culture reveals a tropism for dendritic cells and macrophages. PLoS Biol 2:e432.
37. Wobus CE, Thackray LB, Virgin HW 4th. 2006. Murine norovirus: a model system to study norovirus biology and pathogenesis. J Virol 80:5104-5112.
38. Xavier RJ, Podolsky DK. 2007. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448:427-434.
39. Yamamoto-Furusho JK, Podolsky DK. 2007. Innate immunity in inflammatory bowel disease. World J Gastroenterol 13:5577-5580.
40. Zucchini N, Bessou G, Robbins SH, Chasson L, Raper A, Crocker PR, Dalod M. 2008. Individual plasmacytoid dendritic cells are major contributors to the production of multiple innate cytokines in an organ-specific manner during viral infection. Int Immunol 20:45-56.